Propanc Biopharma Inc
NASDAQ:PPCB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Propanc Biopharma Inc
NASDAQ:PPCB
|
AU |
Income Statement
Earnings Waterfall
Propanc Biopharma Inc
Income Statement
Propanc Biopharma Inc
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Interest Expense |
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||
| Operating Expenses |
(2)
|
(2)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
|
| Selling, General & Administrative |
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Research & Development |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Operating Income |
(2)
N/A
|
(2)
+9%
|
(1)
+10%
|
(1)
-2%
|
(2)
-3%
|
(1)
+8%
|
(1)
+16%
|
|
| Pre-Tax Income | ||||||||
| Interest Income Expense |
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Pre-Tax Income |
(3)
N/A
|
(3)
+10%
|
(3)
-4%
|
(2)
+11%
|
(2)
+17%
|
(2)
0%
|
(2)
+14%
|
|
| Net Income | ||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Net Income (Common) |
(3)
N/A
|
(3)
+16%
|
(3)
-4%
|
(2)
+10%
|
(2)
+18%
|
(2)
+7%
|
(2)
+10%
|
|
| EPS (Diluted) |
-104 228
N/A
|
-14 520.83
+86%
|
-6 819.95
+53%
|
-2 485.52
+64%
|
-1 417.95
+43%
|
-190.29
+87%
|
-126.25
+34%
|
|